BackJapan Tissue Engineering , Ltd. Overview

Japan Tissue Engineering , Ltd. Current Assets

Japan Tissue Engineering , Ltd.'s current assets is $4.3B.

Get informed when a big investor buys or sells

+ Follow
Current Assets
$4.31B
↓ 3.67% YoYΔ $-164.03M vs prior year quarter

Peer trimmed avg / median

Loading

Japan Tissue Engineering , Ltd. Current Assets History

Loading

Japan Tissue Engineering , Ltd. vs. peers: Current Assets Comparison

Loading

Japan Tissue Engineering , Ltd. Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Japan Tissue Engineering , Ltd. (7774.T) FAQ

Japan Tissue Engineering , Ltd. posts a current assets of $4.3B as of September 2026. That compares with $4.5B in the prior-year period — down 3.7% year over year. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, Japan Tissue Engineering , Ltd.'s current assets was $4.5B. The latest reading is $4.3B — a 3.7% year-over-year decrease (period ending September 2026). Use the history and growth charts on this page for a longer lookback.

Current Assets is one piece of Japan Tissue Engineering , Ltd.'s financial statement story. At $4.3B, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for 7774.T's current assets usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Japan Tissue Engineering , Ltd.'s other metric pages and overview cover the third.

Judging Japan Tissue Engineering , Ltd. against Healthcare peers is usually better than using a market-wide rule of thumb. Business models inside Healthcare are more comparable, which makes gaps in current assets easier to interpret. Start with $4.3B here, then scan peer and history charts to see if the gap is persistent.